Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR5 | P35346 | 6/20 | 0.52 |
| ▸ | SSTR3 | P32745 | 5/20 | 0.52 |
| ▸ | SSTR4 | P31391 | 4/20 | 0.52 |
| ▸ | SSTR2 | P30874 | 3/20 | 0.52 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | MCHR1 | Q99705 | 7/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5841003 | 1.00 | SSTR5 (0.52) | SSTR5SSTR3SSTR4SSTR2SSTR1 | |
| SCHEMBL5840925 | 1.00 | SSTR5 (0.52) | SSTR5SSTR3SSTR4SSTR2SSTR1 | |
| SCHEMBL22053387 | 1.00 | SSTR5 (0.52) | SSTR5SSTR3SSTR4SSTR2SSTR1 | |
| SCHEMBL5840823 | 1.00 | SSTR5 (0.52) | SSTR5SSTR3SSTR4SSTR2SSTR1 | |
| SCHEMBL5840827 | 1.00 | SSTR5 (0.52) | SSTR5SSTR3SSTR4SSTR2SSTR1 | |
| SCHEMBL5841004 | 1.00 | SSTR5 (0.52) | SSTR5SSTR3SSTR4SSTR2SSTR1 | |
| SCHEMBL10525210 | 0.94 | SSTR4 (0.51) | SSTR5SSTR3SSTR4SSTR2SSTR1 | |
| SCHEMBL8894417 | 0.93 | SSTR5 (0.54) | SSTR5SSTR3SSTR4SSTR2SSTR1 | |
| SCHEMBL8894414 | 0.93 | SSTR5 (0.54) | SSTR5SSTR3SSTR4SSTR2SSTR1 | |
| SCHEMBL6760495 | 0.93 | POLB (0.57) | SSTR5SSTR3SSTR4SSTR2SSTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2852414-B9 | MENINGOCOCCUS SEROGROUP X CONJUGATE | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2020-12-09 | — | — | EP | disclosed |
| EP-2852414-B1 | MENINGOCOCCUS SEROGROUP X CONJUGATE | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2020-07-08 | — | — | EP | disclosed |
| US-10668143-B2 | Meningococcus serogroup X conjugate | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2020-06-02 | — | — | US | disclosed |
| US-10124051-B2 | Meningococcus serogroup X conjugate | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2018-11-13 | — | — | US | disclosed |
| US-20150104479-A1 | MENINGOCOCCUS SEROGROUP X CONJUGATE | NOVARTIS AG (CH) | 2015-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10668143-B2 | Meningococcus serogroup X conjugate | O60361, MLEC, PDHX | SSTR5 4050/4885SSTR3 4726/4885SSTR4 4815/4885 |
| US-20150104479-A1 | MENINGOCOCCUS SEROGROUP X CONJUGATE | O60361, MLEC, PDHX | SSTR5 4050/4885SSTR3 4726/4885SSTR4 4815/4885 |
| US-10124051-B2 | Meningococcus serogroup X conjugate | O60361, PDHX, MLEC | SSTR5 4282/4885SSTR3 4777/4885SSTR4 4857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.